葛根素:从基础到临床的保肝药物
本文综述葛根素对代谢功能障碍相关脂肪性肝病、酒精相关性肝病和肝癌等多种肝病的保护作用,涉及炎症因子、氧化应激、脂质代谢、凋亡和自噬等机制。葛根素溶解度受限、生物利用度低,新型给药系统可提高其生物利用度;其毒性低、安全性高,相关临床试验显示独特优势,有望成为治疗多种肝病的潜在药物。
要点
- 葛根素对脂肪性肝病、酒精性肝病和肝癌等具有显著保肝作用。
- 其机制涉及炎症因子、氧化应激、脂质代谢、凋亡和自噬等多条通路。
- 葛根素生物利用度低,新型给药系统可改善;毒性低、安全性高。
核心结论
- 葛根素具有多方面保肝药理作用,毒性低、安全性高,有望成为治疗多种肝病的潜在药物。
研究设计与样本
- 本文为综述,围绕葛根素对多种肝病的药理作用、机制、药代动力学、给药系统及临床试验进行讨论。
主要发现
- 葛根素对代谢功能障碍相关脂肪性肝病、酒精相关性肝病和肝癌等具有显著保肝作用。
- 其作用机制涉及炎症因子、氧化应激、脂质代谢、凋亡和自噬。
- 因溶解度受限,药代动力学研究显示葛根素生物利用度低,与新型给药系统联用可提高生物利用度。
- 葛根素毒性很低、安全性高,相关临床试验显示其独特优势。
临床怎么用
- 关注葛根素作为保肝潜在药物的研究进展,临床用药需结合其低生物利用度特点与新型给药策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pueraria is a time-honored food and medicinal plant, which is widely used in China. Puerarin, the main component extracted from pueraria, has a variety of pharmacological characteristics. In recent years, puerarin has received increasing attention for its significant hepatoprotective effects, such as metabolic dysfunction-associated steatotic liver disease, alcohol-related liver disease, and hepatic carcinoma. This paper explores the pharmacological effects of puerarin on various liver diseases through multiple mechanisms, including inflammation factors, oxidative stress, lipid metabolism, apoptosis, and autophagy. Due to its restricted solubility, pharmacokinetic studies revealed that puerarin has a low bioavailability. However, combining puerarin with novel drug delivery systems can improve its bioavailability. Meanwhile, puerarin has very low toxicity and high safety, providing a solid foundation for its further. In addition, this paper discusses puerarin's clinical trials, highlighting its unique advantages. Given its excellent pharmacological effects, puerarin is expected to be a potential drug for the treatment of various liver diseases.
引用
- He YX, Liu MN, Wu H, et al. Puerarin: a hepatoprotective drug from bench to bedside. Chin Med. 2024. PMID: 39380120. doi:10.1186/s13020-024-01011-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。